Ignite Creation Date:
2025-12-24 @ 2:40 PM
Ignite Modification Date:
2025-12-25 @ 1:12 PM
Study NCT ID:
NCT05152459
Status:
WITHDRAWN
Last Update Posted:
2023-05-31
First Post:
2021-11-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tazemetostat in Combination With Umbralisib and Ublituximab for the Treatment Relapsed or Refractory Follicular Lymphoma
Sponsor:
City of Hope Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-05-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-12-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-12-15
Completion Date Type:
ESTIMATED
First Submit Date:
2021-11-26
First Submit QC Date:
None
Study First Post Date:
2021-12-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-26
Last Update Post Date:
2023-05-31
Last Update Post Date Type:
ACTUAL